GSE186034
Gene expression changes in mouse breast cancer cells (EMT6) after anti-PD-L1 treatment
RNA sequencing analysis was used to identify changes in mouse breast cancer (EMT6) following prolonged anti-PD-L1 in vitro (PDRvitro). Overall design: Mouse breast cancer cells (EMT6) were treated with anti-PD-L1 or isotype control for >4 weeks in vitro at 0.5µg/ml before cells were collected for sequencing analysis.